Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Chemoradiotherapy
×
Gastrointestinal
×
Clear all
Filters
3
NCT02301143
2019-03-20
LAPACT
Celgene
Phase 2
Completed
107 enrolled
18 charts
NCT01507103
2017-01-13
SPRINT
Merck KGaA, Darmstadt, Germany
Phase 2
Completed
124 enrolled
9 charts